Establishment of the Veterans Affairs SeqFORCE (Sequencing for Research Clinical and Epidemiology) program for SARS-CoV-2 whole-genome sequencing
American Journal of Clinical Pathology · 2025
DOI: 10.1093/ajcp/aqaf064 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Clinical Pathology, 2025. Verfasst von Mark Holodniy und 14 weiteren Autor:innen. Beteiligte Einrichtung: VHA Office of Public Health, Washington, DC, United States. Hauptthemen laut MEDLINE: COVID-19, Whole Genome Sequencing, SARS-CoV-2. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
Objective
We sought to establish the US Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Sequencing for Research Clinical and Epidemiology (SeqFORCE) multilaboratory consortium for SARS-CoV-2 whole-genome sequencing (WGS).
Methods
Clinical criteria were established for sending patient and employee samples from 145 VHA medical centers to 10 VHA clinical laboratories using 4 different WGS platforms. A linked pipeline among laboratories for SARS-CoV-2 clade and lineage interpretation, result transmission to electronic health records, and data storage was developed.
Results
The SeqFORCE program went live on July 1, 2021. As of December 15, 2024, 51 307 samples have been analyzed by WGS for SARS-CoV-2. The median participant age was 60 years, 76.6% were male, and 13.5% were inpatients; 96.5% were Delta, Omicron, and Recombinant sublineages; and 78.5% represented SARS-CoV-2 postvaccination samples among patients and staff.
Conclusions
Establishment of VA SeqFORCE enabled national population analysis for use in epidemiologic response and population health policy as well as expanded SARS-CoV-2 sequencing capacity to meet the demand for clinical and public health sequencing. The program consolidated operations using standardized procedures, test setup, analysis, reporting, and tracking. It also improved oversight and governance of VA contributions to global databases, mitigated system inefficiencies, and prepared VHA for future genomic challenges.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- VHA Office of Public Health, Washington, DC, United States.
- Stanford University, Stanford, CA, United States.
- Boise VA Medical Center, Boise, ID, United States.
- VA Connecticut Healthcare System, West Haven, CT, United States.
- Indianapolis VA Medical Center, Indianapolis, IN, United States.
- VA Eastern Colorado Health Care System, Denver, CO, United States.
ORCID-Profile: Mark Holodniy, Vafa Bayat
Zitieren
APA
Holodniy, M., Pei, Y., Stack, G., Wade, C., Agrawal, Y., Barasch, N., Baddoura, F., Kletecka, C., Adegboyega, P., Trevino, C., Mewton, J., Bayat, V., Mostaghimi, A., Klutts, J. S., & Wang-Rodriguez, J. (2025). Establishment of the Veterans Affairs SeqFORCE (Sequencing for Research Clinical and Epidemiology) program for SARS-CoV-2 whole-genome sequencing. American Journal of Clinical Pathology. https://doi.org/10.1093/ajcp/aqaf064
Vancouver
Holodniy M, Pei Y, Stack G, Wade C, Agrawal Y, Barasch N, et al. Establishment of the Veterans Affairs SeqFORCE (Sequencing for Research Clinical and Epidemiology) program for SARS-CoV-2 whole-genome sequencing. American Journal of Clinical Pathology. 2025. doi:10.1093/ajcp/aqaf064
BibTeX
@article{Holodniy2025,
author = {Holodniy, Mark and Pei, Ying and Stack, Gary and Wade, Christopher and Agrawal, Yashpal and Barasch, Nicholas and Baddoura, Fady and Kletecka, Carmen and Adegboyega, Patrick and Trevino, Christina and Mewton, Joel and Bayat, Vafa and Mostaghimi, Anosh and Klutts, James S and Wang-Rodriguez, Jessica},
title = {Establishment of the Veterans Affairs SeqFORCE (Sequencing for Research Clinical and Epidemiology) program for SARS-CoV-2 whole-genome sequencing},
journal = {American Journal of Clinical Pathology},
year = {2025},
doi = {10.1093/ajcp/aqaf064}
}
EUVIMED